2026 NPPES data Gynecologic Oncology Physician NPI 1902085822 MD
Verify on CMS →

SARA JORDAN, MD

Gynecologic Oncology Physician in RIO RANCHO, New Mexico. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
304
Medicare Part D claims · 90 beneficiaries · Gynecologic Oncology Physician avg: 188
Generic prescribing
78%
generic claims · 22% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
83.8451/100
▲ 1 pts above national avg 83.1 · [object Object]
Industry payments
$585.21
20 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: SARA JORDAN, MD is a Gynecologic Oncology Physician ([object Object]) practicing in RIO RANCHO, New Mexico with a Medicare Part D prescribing footprint of 304 claims across 90 beneficiaries — 22% brand-name prescribing . Their CMS MIPS Final Score of 83.8451/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $585.21 across 20 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: SARA JORDAN, MD reported a CMS MIPS final score of 83.8451 out of 100, above the 83.1 national average, and filed 304 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

SARA JORDAN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

SARA JORDAN, MD at a glance

Near national average

NPI registry status

Active

Issued 10/27/2007

NPI 1902085822

Primary specialty

Gynecologic Oncology Physician

Niche

1,360 US NPIs in this specialty

Medicare Part D claims

304 62% vs specialty avg

2023 prescription claims

Specialty avg: 188

MIPS final score

83.8451/100 0.7451000000000079% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in New Mexico

How Gynecologic Oncology Physician compares to other specialties among New Mexico providers

New Mexico providers

Gynecologic Oncology Physician share within New Mexico

1. Gynecologic Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Gynecologic Oncology Physician share within New Mexico

Medicare quality performance — MIPS

SARA JORDAN, MD's 2023 MIPS final score plotted against the Gynecologic Oncology Physician national average

Near national average
MIPS Final Score
83.8451/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Gynecologic Oncology Physician) — 83.8451/100 vs national avg 83.1

0%100%National avg83%83.8%
MIPS final score (Gynecologic Oncology Physician) — 83.8451/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SARA JORDAN, MD is a Gynecologic Oncology Physician provider practicing in RIO RANCHO, New Mexico, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1902085822. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

SARA JORDAN, MD appears in the CMS NPPES registry as a Gynecologic Oncology Physician provider holding MD credentials at 2400 UNSER BLVD SE, RIO RANCHO, NM, 87124, with a listed phone of (505) 559-6100. NPI 1902085822 was issued on 10/27/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what JORDAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 304 prescription claims written by this provider, covering 90 Medicare beneficiaries and totaling roughly $552K in drug spend, split 22% brand-name and 78% generic by claim count, with an opioid prescribing rate of 3.6%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 83.8451/100 for the 2023 performance year (Quality 84.5974, Cost 58.6394), compared with the national average of 83.1.

Gynecologic Oncology Physician is a narrow specialty nationwide, with 1,360 enrolled providers across 49 states and an average of 188 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2400 UNSER BLVD SE
RIO RANCHO, NM 87124

Provider Details

NPI 1902085822
Specialty Gynecologic Oncology Physician
Credentials MD
Gender Female
NPI Issued 10/27/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

83.8451
Final Score
Avg: 83.1
84.5974
Quality
58.6394
Cost
100
Promoting Interoperability

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SARA JORDAN, MD. Source: openpaymentsdata.cms.gov.

Total received

$585

Largest payer

Genmab U.S., Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

SARA JORDAN, MD — brand share 22.0%
Specialty average (est.)

22% brand-name claims vs 78% generic, on 304 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

304
Total Claims
$552K
Total Drug Cost
90
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
352
Total Day Supply
7,505
Brand vs Generic
22% brand / 78% generic
Brand Drug Cost
$497K
Generic Drug Cost
$55K
Opioid Claims
11 (3.6% rate)
Antibiotic Claims
13

Patient Demographics

Average Patient Age
72.1 years
Avg HCC Risk Score
1.89
Gender Split
100% female / 0% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Lynparza
Olaparib
38
Ondansetron Hcl
26
Prochlorperazine Maleate
22
Lidocaine-Prilocaine
Lidocaine/Prilocaine
20
Ibuprofen
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Gynecologic Oncology Physician Overview

How SARA JORDAN, MD fits within the Gynecologic Oncology Physician landscape nationally.

1,360
Gynecologic Oncology Physician Providers in US
49
States with Gynecologic Oncology Physician
188
Avg Claims per Provider

SARA JORDAN, MD's 304 claims are above the specialty average of 188.

Nearby Gynecologic Oncology Physician Providers in New Mexico

Other clinicians with the same primary specialty enrolled in New Mexico, drawn from the same CMS NPPES roster as JORDAN.

Compare Gynecologic Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SARA JORDAN, MD's specialty?
SARA JORDAN, MD specializes in Gynecologic Oncology Physician and practices in RIO RANCHO, New Mexico. Credentials: MD.
How much does SARA JORDAN, MD prescribe under Medicare Part D?
In 2023, SARA JORDAN, MD wrote 304 Medicare Part D claims totaling $552K in drug costs for 90 beneficiaries.
What is SARA JORDAN, MD's Medicare quality score?
SARA JORDAN, MD has a CMS MIPS Final Score of 83.8451/100 (Quality: 84.5974, Cost: 58.6394). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is SARA JORDAN, MD located?
SARA JORDAN, MD is located at 2400 UNSER BLVD SE, RIO RANCHO, NM, 87124. Phone: (505) 559-6100.
What is SARA JORDAN, MD's NPI number?
SARA JORDAN, MD's National Provider Identifier (NPI) is 1902085822, issued on 10/27/2007.
Does SARA JORDAN, MD prescribe more brand-name or generic drugs?
SARA JORDAN, MD's prescribing is 22% brand-name and 78% generic drugs by claim count, with $497K in brand drug costs.
Does SARA JORDAN, MD prescribe opioids?
Yes, SARA JORDAN, MD had 11 opioid claims in 2023 with an opioid prescribing rate of 3.6%.
How many Gynecologic Oncology Physician providers are there in the US?
There are 1,360 Gynecologic Oncology Physician providers across 49 states in the US. The average Gynecologic Oncology Physician provider writes 188 Medicare Part D claims per year.
What drugs does SARA JORDAN, MD prescribe most often?
Based on 2023 Medicare Part D data, SARA JORDAN, MD's most frequently prescribed drugs include Lynparza, Ondansetron Hcl, Prochlorperazine Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SARA JORDAN, MD accept Medicare?
SARA JORDAN, MD appears in CMS Medicare data with 304 Part D claims and 90 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SARA JORDAN, MD's credentials?
SARA JORDAN, MD's NPI is 1902085822 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology